CHRONIC TNF NEUTRALIZATION (UP TO 1-YEAR) BY LENERCEPT (TNFR55-IGG1, RO-45-2081) IN PATIENTS WITH RHEUMATOID-ARTHRITIS - RESULTS OF AN OPEN-LABEL EXTENSION OF A DOUBLE-BLIND SINGLE-DOSE PHASE-I STUDY
F. Hasler et al., CHRONIC TNF NEUTRALIZATION (UP TO 1-YEAR) BY LENERCEPT (TNFR55-IGG1, RO-45-2081) IN PATIENTS WITH RHEUMATOID-ARTHRITIS - RESULTS OF AN OPEN-LABEL EXTENSION OF A DOUBLE-BLIND SINGLE-DOSE PHASE-I STUDY, Arthritis and rheumatism, 39(9), 1996, pp. 1292-1292